All Products
B
M
R
S
U
W
Z
Find industry news, trends, and innovative products right here in our blog.
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
R
S
V
W
X
Discover whether Evenity is a bisphosphonate or a different type of treatment for osteoporosis. Learn how it works and how it compares...
Find out how long Evenity stays in your system, its effects on bone mineral density, and why transitioning to antiresorptive therapy is...
Learn about the Evenity dosing schedule, including monthly injection timing, treatment duration, and clinical considerations for osteoporosis management.
Discover how Evenity and Prolia differ in treating osteoporosis, including their mechanisms, benefits, and the role of sequential therapy in fracture prevention.
Explore Evenity’s side effects, from joint pain to cardiovascular risks, and learn safety tips for managing treatment and ensuring bone health.
Learn about Entyvio’s FDA approval, its gut-selective action, and the recent subcutaneous formulation approval for ulcerative colitis and Crohn’s disease.
Discover how Entyvio works differently from traditional immunosuppressants. Learn about its gut-selective action, safety profile, and benefits for managing ulcerative colitis and...
Review the Entyvio dose schedule, from induction to maintenance, and learn how vedolizumab infusion timing supports long-term control of ulcerative colitis and...
Review key Entyvio prescribing information for practitioners, including dosing, administration, contraindications, and safety guidance for ulcerative colitis and Crohn’s disease.
Learn how Takeda Oncology, the manufacturer of Entyvio (vedolizumab), advances gut-selective treatments and leads innovation in inflammatory bowel disease care.
Learn about vedolizumab, the generic name for Entyvio—its structure, mechanism, biologic class, and biosimilar status in treating gut inflammation.
Learn what Entyvio is used for in ulcerative colitis, Crohn’s disease, and pouchitis—its dosing, clinical benefits, and gut-selective mechanism of action.